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Abstract 
Background:. To assess the frequency of QTc 
prolongation in patients with liver cirrhosis and to 
observe its association with the severity of cirrhosis. 
Methods: This cross-sectional observational study  
included 189 diagnosed cases of liver cirrhosis who 
were consecutively recruited and categorized 
according to Child-Pugh class, to rate the severity. 
QTc interval prolongation was observed, and its 
association with Child-Pugh class scores (severity of 
Liver Cirrhosis) was assessed using Chi-square test 
keeping p-value less than 0.05 as statistically 
significant. 
Results: The mean age of the participants was 51.25 
±14.34, and gender distribution showed that96 (51%) 
were male and 93 (49%) were female. Q-Tc interval 
was normal in 99 (52%) patients and was prolonged 
in 90 (48%) patients. The QT-c interval prolongation 
was significantly associated with severity of liver 
cirrhosis. (p-value =0.000) 
Conclusion: QTc interval was prolonged in almost 
half of the patients and the frequency of prolonged 
QTc   was directly proportional to the severity of the 
hepatic cirrhosis according to Child-Pugh criteria. 
Key Words: Liver Cirrhosis, Long QT syndrome, 
Cardiomyopathies. 
Introduction 
Cirrhotic cardiomyopathy is one relatively common 
cardiovascular complication arising secondary to liver 
cirrhosis. The prolongation of QTc interval has been 
found in various studies to be linked directly to the 
severity of liver cirrhosis. Liver cirrhosis refers to 
scarring of the liver which results in abnormal liver 
function as a consequence of chronic liver injury.1,2 It is 
a major cause of mortality and morbidity worldwide.3 
It is also a common cause of mortality amongst 
Pakistani population and frequent cause of admission 
in our hospitals.4 Cirrhosis is a leading cause of illness 
and death in the United States.5Cirrhosis of the liver is 
a consequence of long-term liver injury of many types. 
The most common cause being viral hepatitis as 
compared to West where alcohol is more common.6,7 
Majority of patients (90%) with chronic liver disease 
have evidence of Hepatitis B Virus, Hepatitis C Virus 
or co-infection. Disease is reported more severe in 
patients with co-infection and cirrhosis is recorded in 
74% of patients.8,9 HCV is now more common as 
compared to HBV in our country, and a high 
frequency of HCV seropositive individuals of both 
genders among patients referred for chronic liver 
disease.10 
Portal hypertension, ascites and variceal haemorrhage 
are common complications in cirrhotic patients. 
Esophagogastric varices have the greatest clinical 
impact, with a risk of mortality of 17–42% per bleeding 
episode. Ascites, important complication of advanced 
cirrhosis and severe portal hypertension, is sometimes 
refractory to treatment and is complicated by 
spontaneous bacterial peritonitis and hepatorenal 
syndrome.11,12  Hepatic encephalopathy is another 
complication, with a mortality of about 30%.13 
The effects of cirrhosis on cardiovascular and 
circulatory system are not well studied.14 The use of 
new investigative modalities has shown several lines 
of evidence of impaired cardiac contractility and 
performance in patients with cirrhosis and has led to 
the introduction of the new clinical entity, cirrhotic 
cardiomyopathy. Cirrhotic cardiomyopathy is a new 
clinical entity, which is diagnosed infrequently 
because of relative unawareness regarding this entity. 
It has many features including prolongation of QTc 
interval, increased heart rate, decreased myocardial 
contraction force and diastolic dysfunction.15A 
prolonged QTc duration in chronic liver disease could 
potentially lead to ventricular arrhythmias and sudden 
cardiac death.16-18 
Patients and Methods 
This was a descriptive cross-sectional study which was 
conducted at the Gastroenterology Department of 
Pakistan Institute of Medical Sciences from December 
toh June 2010.A total of 189 diagnosed cases of 
cirrhosis i.e Ultrasound proven cirrhosis with 
shrunken liver less than 9 cm, portal vein diameter 
more than 12 mm and  splenomegaly of more than 
12cm, were enrolled in the study. The patients with 
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congestive cardiac failure, primary biliary cirrhosis, 
ischemic heart disease, hypertension, valvular heart 
diseases, heart block, cardiomyopathy and recent use 
of drugs affecting QT interval less than 72 hours, were 
excluded. Blood samples were taken for bilirubin, 
albumin and prothrombin time . All patients 
underwent ultrasound.Electrocardiography was done 
by using standardized 12 lead ECG modules with 
speed of 25mm/s and voltage of 1mV, and QT interval 
was measured and QTc was calculated. Chi-square 
test was applied to associate severity of 
cirrhosis(Child-Pugh class) with prolonged QTc 
interval, keeping p value less than 0.05 statistically 
significant. 
Results 
Out of 189, 96 (51%) were male and 93 (49%) were 
female. Most of the cirrhotic patients belonged to age 
group from 45 to 65 years of age (Range 18-90).Mean 
age was 51.25 ±14.34 . Majority belonged to Child- 
Pugh class C (57%)(Table 1). QTc interval  was 
prolonged in 90 (48%) patients (Table 2). Chi-square 
test revealed a significant association between severity 
of liver cirrhosis and prolongation of Q-tc interval with 
p-value =0.00 (<0.05) (Table 3 &4) 
Table 1: Distribution of Child-Pugh Class in 
Study Population 
Child-Pugh Class  No(%) 
Class A 22(11) 
Class B 60(32%) 
Class C 108 (57%) 
Table 2: QTc Interval in patients with cirrhosis  
QTc interval No(%) 
Normal 99(52) 
Prolonged 90(48) 
Table 3:  Association between severity of 
cirrhosis and QT interval prolongation (Child-
Turcot-Pugh  QTc Interval Cross tabulation) 
Child-Turcot-
Pugh class 
QTc Interval Total 
Normal Prolonged 
Class A 16 5 21 
Class B 40 20 60 
Class C 43 65 108 
 
Table 4:  Association between severity of 
cirrhosis and QTc interval prolongation 
Chi-Square  DF *p-Value 
16.52 2 0.00 
*p- Value less than 0.05 considered statistically significant 
 
Discussion 
In our study almost half of the patients had prolonged 
Q-Tc interval. This prolonged  Q-Tc interval was 
found in all classes of the Child-Turcot-Pugh from A to 
C. But frequency of prolonged Q-Tc interval was much 
less in patients belonging to child class A, where only 
6% of the patients had prolonged interval. On the 
other hand in patients belonging to child class B, 22% 
of the patients had prolonged QTc interval and in the 
patients who were most serious, i.e. in class C, 72% of 
the patients had abnormally prolonged Q-Tc interval. 
In present study frequency of prolonged QTcinterval   
was found  less prevalent in Child class A patients. Its 
frequency had slightly increased in Child class B and 
in class C which is the worst class of Child’s criteria, 
the frequency of prolonged QTc interval had reached 
to 72%. The frequency of the prolonged or abnormal 
QTc interval is directly proportional to the severity of 
the liver cirrhotic disease according to the Child –
Turcot-Pugh class and this association was statistically 
significant i.e p value =0.00 ( < 0.05). 
In another trial conducted in Italy by Genovesi S et al, 
it was found that QTc interval was progressively 
prolonged from Child class A to Child Class C with 
significant P value.  19 There was  a positive correlation 
between prolonged QTc interval and hepatic vein 
pressure gradient and it was found that frequency of 
prolonged QTc is increased with the increase in Child 
class and also with increase in hepatic vein pressure 
gradients. It might be due to the presence of severe 
portal hypertension that was associated with 
decreased heart rate variability.Cirrhotic patients with 
a more severe disease, especially of alcoholic etiology, 
who have greater HVPG (hepatic vein pressure 
gradients) and lower calcium plasma levels, have an 
altered ventricular repolarization and a reduced vagal 
activity to the heart, which may predispose to life-
threatening arrhythmias.Study of   Bashir A et al, 
found that  frequency of QTc prolongation was 4.5% in 
Child PughGrade A, 23.2% in Child Pugh Grade B, 
and 32.0% in Child Pugh Grade C. Association of 
Child Pugh Scoring with QTc prolongation was 
determined and found to be statistically significant (p 
< 0.05).20 The results presented by Zuberi et al. in their 
study, in which they showed the frequency of QTc 
prolongation to be 19.2%. 21 This is much in contrast 
with our study as the current study findings revealed 
the frequency of QTc prolongation to be 48%. But a 
wide range of values are available across a number of 
International studies. 
It was found to be 46.2% in a study by Bernardi et al, 
46.93% in a study by Li et al. Bal et al  demonstrated a 
QTc prolongation frequency of 56%in their study. 23,24 
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Kosar et al  determined the frequency of QTc 
prolongation to be 32% in their study population. 25 
This discrepancy may be explained by the presence of 
other compounding factors such as electrolyte 
disturbances, concomitant cardiac problems, or use of 
QTc prolonging drugs, which were excluded in our 
study but might have been included in other studies. 
Moreover, the variable spread of severity of cirrhosis 
as shown by Child Pugh Score or any other model in 
all these studies would also have played a role in this 
wide range of results. 
A direct relationship between the stage of cirrhosis 
and the development of cirrhotic cardiomyopathy has 
been consistently observed in various studies. More 
advanced the cirrhosis, the greater the chances of 
developing cirrhotic cardiomyopathy and the 
associated symptoms, as evident from the current 
study finding suggesting a statistically significant 
association between severity of Cirrhosis and QTc 
prolongation.  
Conclusion 
1.Q-Tc interval was prolonged in almost half of the 
patients and the frequency of prolonged Q-Tc   was 
directly proportional to the severity of the hepatic 
cirrhosis according to Child-Pugh criteria.  
2. The healthcare providers must be mindful of this 
serious complication and must carefully evaluate such 
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